What question did this study set out to answer?

This research aims to synthesize and evaluate new compounds that can manage severe pain with fewer side effects than traditional opioids.

February 14, 2026RSC Medicinal Chemistry0 citationsOpen Access

Evaluation of 14β-Acyl Substituted Cyclopropylmethyl Morphinone Derivatives

Synthesis and evaluation of 14β-acyl substituted 17cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors

View Full Paper

Ask AI

Bookmark

Authors

MOMehrnoosh Ostovar KOKeith Olsen GCGerta Cami-Kobeci

Discussion

Member takes

Overview

Evaluation of mixed partial agonists at mu opioid and nociception receptors for pain management, suggesting new treatment options.

Key Points

This research aims to synthesize and evaluate new compounds that can manage severe pain with fewer side effects than traditional opioids.
Synthesize 14β-acyl substituted 17cyclopropylmethyl-7,8-dihydromorphinone derivatives.
Evaluate their activity as mixed partial agonists at mu opioid and nociception receptors.
Analyze their potential as analgesics in comparison to standard opioids.
Identified new derivatives with partial agonist properties at mu opioid receptors.
Showed reduced adverse effects compared to traditional opioids.
Suggested potential as effective treatments for chronic pain management.

Cite This Study

Ostovar et al. (2026) studied this question.

synapsesocial.com/papers/699010ce2ccff479cfe570cb https://doi.org/10.1039/d5md00685f

View Full Paper

Ask AI

Bookmark

February 14, 2026RSC Medicinal Chemistry0 citationsOpen Access

Evaluation of 14β-Acyl Substituted Cyclopropylmethyl Morphinone Derivatives

Synthesis and evaluation of 14β-acyl substituted 17cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors

View Full Paper

Ask AI

Bookmark

Authors

MOMehrnoosh Ostovar KOKeith Olsen GCGerta Cami-Kobeci

Discussion

Member takes

Overview

Evaluation of mixed partial agonists at mu opioid and nociception receptors for pain management, suggesting new treatment options.

Key Points

This research aims to synthesize and evaluate new compounds that can manage severe pain with fewer side effects than traditional opioids.
Synthesize 14β-acyl substituted 17cyclopropylmethyl-7,8-dihydromorphinone derivatives.
Evaluate their activity as mixed partial agonists at mu opioid and nociception receptors.
Analyze their potential as analgesics in comparison to standard opioids.
Identified new derivatives with partial agonist properties at mu opioid receptors.
Showed reduced adverse effects compared to traditional opioids.
Suggested potential as effective treatments for chronic pain management.

Cite This Study

Ostovar et al. (2026) studied this question.

synapsesocial.com/papers/699010ce2ccff479cfe570cb https://doi.org/10.1039/d5md00685f

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark